Label Decoder
Report new or worsening mood changes
Official label information
Antiepileptic drugs including gabapentin increase the risk of suicidal thoughts or behavior. Labeling asks patients, families, and caregivers to watch for new or worsening depression, unusual mood or behavior, or thoughts of self-harm, for any indication.
Plain-language explanation
This warning asks patients and caregivers to notice meaningful changes in mood, behavior, agitation, or thoughts of self-harm. It is a safety prompt, not a diagnosis.
What this often means for gabapentin products
This is a monitoring warning, not a prediction. Immediate danger requires emergency or crisis services. Do not increase gabapentin on your own to “treat mood.”
Ask your pharmacist
Ask which changes merit an urgent call and what crisis resource to use outside office hours.
Sources
- DailyMed: NEURONTIN (gabapentin) capsules, tablets, and oral solution — U.S. National Library of Medicine
- MedlinePlus: Gabapentin — MedlinePlus / National Library of Medicine
This decoder does not diagnose, set a personal dose, or create a taper schedule. If two instructions conflict, pause and ask the dispensing pharmacist.